UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 31st DECEMBER, 2004
(RS. IN LACS)
PARTICULARS
Three
Three
Nine
Nine
Year
months
months
Months
Months
months
31.12.04
31.12.03
31.12.04
31.12.03
31.3.2004
Unaudited
Unaudited
Unaudited
Unaudited
Audited
Net Sales/Operational Income
6674.68
4450.89
15622.73
12129.87
16652.16
Others Income
2.92
37.03
35.36
71.37
193.11
TOTAL EXPENDITURE :
5254.82
3953.25
12458.68
10676.20
14688.67
(a) (Increase)/decrease in stock in trade
-346.55
-467.97
-1227.46
-651.63
-675.87
(b) Consumption of Raw Material
4565.65
3565.79
10654.27
9140.90
12256.41
(c) Staff Cost
78.25
82.15
293.68
220.70
245.21
(d) Other expenditure
957.48
773.29
2738.19
1966.23
2862.92
Interest
220.71
135.21
584.14
515.15
708.31
Depreciation
103.87
74.56
286.84
198.83
278.67
Profit(+)/Loss(-) before tax
1098.21
324.89
2328.42
811.06
1169.62
Provision for taxation
98.17
24.58
194.64
59.33
75.48
Net Profit/Loss before Deferred Tax
1000.03
300.31
2133.78
751.73
1094.14
Provision for deferred tax
246.96
60.13
392.46
157.55
324.98
Net Profit/Loss
753.07
240.18
1741.32
594.18
769.17
Paid up Equity Share Capital
1783.87
1438.63
1561.37
Reserve excluding revaluation reserves
7659.32
3106.68
3581.75
EPS Rs.
-
Basic
4.77
1.58
11.03
4.18
5.24
- Diluted
-
4.46
1.58
10.31
4.18
4.87
Notes:
a) During the Quarter under review the turnover
of Company increased by 49.9%, whereas the Export turnover increased by 48.9%. The
Net Profit after tax has increased by 213.54% over the corresponding figures of
previous year quarter.
b) 36 Complaints were received during the quarter,
which were duly redressed to the satisfaction of Shareholders. There was no complaint
pending as on 31st December, 2004.
c) The previous period figures have been re-grouped
and re-arranged whenever necessary.
d) The company is exclusively in the Pharmaceutical
business segment.
e) The previous period figures have been re-grouped
and re-arranged wherever necessary.
f) The above results were taken on record by
the board of directors in its meeting held on 31st January, 2005.
For Ind-Swift Laboratories Limited
Sd/-
Sd/-
Place:Chandigarh
(N.R.MUNJAL)
(V.K.MEHTA)
Date:31.01.2005
Managing Director
Jt.Managing Director
To know about our Formulation Division, please visit us at Ind-Swift Limited, our other
group company.
